TRI-CON 2025 Poster Presentations Coming in February
Here is a reminder of the 2024 presentations:
P01: A Prospective-Retrospective Study Design to Validate a Landmark MRD Assay in Lung Cancer, Presented by Kelly O., AstraZeneca
P02: Development of a Microbead-Based Immunoassay Using qPCR for the Detection of Amyloid-Beta (1-42), Presented by Jennifer P., Brown University
P03: HCR Lateral Flow Assays for Amplified Instrument-Free At-Home SARS-CoV-2 Testing, Presented by Nikhil L., California Institute of Technology
P04: Decoding the Intercellular Signals Underlying Human Glia Plasticity, Presented by Natacha CL., Columbia University
P05: A PCR Assay to Detect cfDNA from Dying Neurons and Glia, Presented by Jason R., CSIRO - Commonwealth Scientific and Industrial Research Organisation
P06: Quantitating Lateral Flow Tests by Eye: Issues and Observations, Presented by John S., DCN Dx
P07: Demonstration of Successful Liquid Biopsy Analyses on Samples from Extensive Biobank and Implications for Research and Clinical Applications, Presented by Meredith O., Discovery Life Sciences
P08: Returning Personalized, Genetic Health Test Results to Individuals of African Descent or Ancestry in Precision Medicine Research, Presented by Nora E., Duke University
P09: Comparative Analysis of Bioethical Considerations in Real-World Mental Health Data Regulation, Presented by Laura W., Duke University
P10: Develop a Targeted DNA Methylation and Mutation-Based Multi-Cancer Detection Test, Presented by Collin H., EpigenDx, Inc.
P11: Yield and Purity of EV Isolation Methods, Presented by Amber M., Exokeryx, Inc.
P12: The Clinical Utility of Extracellular Vesicles in Liquid Biopsy, Presented by Adam L., FYR Diagnostics
P13: Method to Observe Air Bubble Removal in MDx Panels, Presented by Cordula S., WL Gore & Associates GmbH
P14: Defining Priorities in Value-Based Cancer Care: Insights from Surveys of US Payers, Presented by Julie W., Guardant Health
P15: Identifying Novel and Known Gene Fusions in Solid Tumors Using DNA/RNA Sequencing, Presented by Sourat D., Hoag Family Cancer Institute
P16: Miniaturization of qPCR and Genomics Workflows Using the Tecan Uno Single Cell Dispenser™, Presented by Christie D., HP, Inc.
P17: Validation of a Vector Copy Number (VCN) Digital Droplet (dd) PCR Test for the Detection of Anti-CD20 CAR T Cells in the Phase 1 Clinical Trial of ADI-001, Presented by Sara B., ICON plc
P18: Combinatorial Functional Precision Medicine with Small Data AI Platform, Presented by Sudha S.,, KYAN Technologies
P19: Rapid Interactive Analysis of NanoString CosMx Spatial Molecular Imager Transcriptomes, Presented by Tadafumi I., Mayo Clinic
P20: Using Xenopus Epithelium to Study the Effects of Photobiomodulation Therapy, Presented by Rosa V., Midwestern University
P21: AMAnD: An Automated Metagenome Anomaly Detection Methodology Utilizing DeepSVDD Neural Networks, Presented by Colin P., MRIGlobal
P22: Molecular Detection of Urinary Tract Infections, Presented by Cameron C., Nanopath, Inc.
P23: Development and Validation of Methylated cfDNA Reference Materials for Liquid Biopsy Measurements, Presented by Zhiyong H., National Institute of Standards and Technology
P24: Multiplex Detection of the Big Five Carbapenemase Genes Using Solid-Phase Recombinase Polymerase Amplification, Presented by Christopher J., Newcastle University
P25: Rapid Ultra-Sensitive Diagnosis of Clostridium difficile Infection Using a SERS-Based Lateral Flow Assay, Presented by Neil K., Newcastle University
P26: RiboMarker: Novel Approach Using NGS of Fragmented Cell-Free RNA for Accurate, Dynamic Liquid Biopsy, Presented by Sergio BS., RealSeq Biosciences
P27: Development of Early Detection of Pandemic Outbreak Using AI-Augmented Wearable Datasets, Presented by Jorge S., Sandia National Laboratories
P28: STI Scout: Molecular Chlamydia and Gonorrhea Testing for Home Use, Presented by Cameron B., Scout
P29: Respiratory Scout: Influenza A, B and SARS-CoV-2 Multiplex RT-LAMP Test for Home Use, Presented by Rochelle N., Scout
P30: Isothermal Nucleic Acid Amplification Test Developed for Site-Specific Detection and Differentiation, Presented by Paul L., Simon Fraser University
P31: Detection of BRCA1/2 and HRR Variants in Cell-Free DNA with NGS-Based Prostate Cancer Applications, Presented by Alex T., SOPHiA GENETICS SA
P32: Early Sepsis Recognition at Initial Clinical Presentation Using the Triverity™ Acute Infection and Sepsis Test - A First Real-World Study by Acutelines, Presented by Hjalmar B., University Medical Center Groningen
P33: Design, Characterization, and Selective Delivery of Fibroblast Activation Protein Targeted Nanomedicine for the Suppression of Fibroblast-Like Synoviocyte Activation in Rheumatoid Arthritis (RA), Presented by Iqra A., University of Illinois
P34: Evaluating Biocompatibility and Anti-Angiogenesis Efficiency of Anti-Integrin PEG-b-PPS Micelles in Danio rerio Diabetic Retinopathy Model, Presented by Aishwarya G., University of Illinois
P35: Identification of Genomic Mutations in Prostate Cancer and Cancer Stem Cells by Single Cell RNAseq Analysis, Presented by Wen-Yang H., University of Illinois
P36: Gold Anchored-Tryptamine Nanoliposomes (Trpn-Au-Lipo): An Anti-Inflammatory and Anti-Amyloidogenic Nanomaterial for the Treatment of Alzheimer’s Disease, Presented by Sakshi J., University of Illinois
P37: Rationale Design of Denatured Collagen-Binding Micelles for Tumor-Targeted Drug Delivery, Presented by Akshada M., University of Illinois
P38: BBB-Targeted Hybrid Nanocarriers for Trans-Cinnamaldehyde (TCA) Delivery to Reduce Amyloid β Fibrillation in Alzheimer's Disease, Presented by Evan T., University of Illinois
P39: Uncovering the Human and Canine Gut Virome Using Cutting-Edge Sequencing Techniques, Presented by Zsolt B., University of Szeged
P40: Cross-Comparison of Gut Metagenomic Profiling Strategies, Presented by Dora T., University of Szeged
P41: Providing Clinical Decision Support to Providers and Value to Patients: The US Department of Veterans Affairs (VA) National Pharmacogenomics Program (NPP), Presented by Rona R., VA Palo Alto Health Care System
P42: Revolutionizing Lab-on-Chip Dynamics with Wafer-Level Photonic Integrations, Presented by Hsin-Yi H., VisEra Technologies Company Ltd.